Climb Bio Stock Price History

CLYM Stock   1.95  0.08  3.94%   
If you're considering investing in Climb Stock, it is important to understand the factors that can impact its price. As of today, the current price of Climb Bio stands at 1.95, as last reported on the 21st of December, with the highest price reaching 2.12 and the lowest price hitting 1.89 during the day. Climb Bio secures Sharpe Ratio (or Efficiency) of -0.4, which signifies that the company had a -0.4% return per unit of risk over the last 3 months. Climb Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Climb Bio's Risk Adjusted Performance of (0.30), standard deviation of 5.03, and Mean Deviation of 3.91 to double-check the risk estimate we provide.
  
At this time, Climb Bio's Total Stockholder Equity is very stable compared to the past year. As of the 21st of December 2024, Common Stock Shares Outstanding is likely to grow to about 28.6 M, while Capital Stock is likely to drop 2,565. . Climb Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.4002

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCLYM

Estimated Market Risk

 4.96
  actual daily
44
56% of assets are more volatile

Expected Return

 -1.98
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.4
  actual daily
0
Most of other assets perform better
Based on monthly moving average Climb Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Climb Bio by adding Climb Bio to a well-diversified portfolio.

Climb Bio Stock Price History Chart

There are several ways to analyze Climb Stock price data. The simplest method is using a basic Climb candlestick price chart, which shows Climb Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 14, 20245.44
Lowest PriceDecember 19, 20241.95

Climb Bio December 21, 2024 Stock Price Synopsis

Various analyses of Climb Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Climb Stock. It can be used to describe the percentage change in the price of Climb Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Climb Stock.
Climb Bio Price Rate Of Daily Change 0.96 
Climb Bio Price Action Indicator(0.09)
Climb Bio Price Daily Balance Of Power(0.35)

Climb Bio December 21, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Climb Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Climb Bio intraday prices and daily technical indicators to check the level of noise trading in Climb Stock and then apply it to test your longer-term investment strategies against Climb.

Climb Stock Price History Data

The price series of Climb Bio for the period between Sun, Sep 22, 2024 and Sat, Dec 21, 2024 has a statistical range of 6.48 with a coefficient of variation of 33.76. The prices are distributed with arithmetic mean of 4.2. The median price for the last 90 days is 3.83.
OpenHighLowCloseVolume
12/21/2024
 2.02  2.12  1.89  1.95 
12/19/2024 2.02  2.12  1.89  1.95  365,130 
12/18/2024 2.32  2.34  2.02  2.03  380,273 
12/17/2024 2.37  2.48  2.30  2.34  171,081 
12/16/2024 2.63  2.64  2.40  2.42  196,100 
12/13/2024 2.90  2.90  2.57  2.60  137,138 
12/12/2024 3.08  3.10  2.78  2.82  160,600 
12/11/2024 3.11  3.15  3.05  3.10  130,644 
12/10/2024 3.19  3.19  3.03  3.08  144,548 
12/09/2024 3.05  3.21  3.03  3.18  194,300 
12/06/2024 2.92  3.03  2.92  3.02  115,007 
12/05/2024 3.09  3.09  2.89  2.91  151,663 
12/04/2024 3.15  3.19  3.07  3.09  103,533 
12/03/2024 3.27  3.27  3.10  3.15  139,094 
12/02/2024 3.25  3.30  3.21  3.26  118,760 
11/29/2024 3.24  3.29  3.19  3.23  62,900 
11/27/2024 3.08  3.22  3.02  3.22  133,182 
11/26/2024 3.11  3.11  3.00  3.04  111,270 
11/25/2024 3.06  3.25  3.04  3.08  209,556 
11/22/2024 3.11  3.30  3.02  3.05  184,337 
11/21/2024 3.09  3.12  2.90  3.00  163,940 
11/20/2024 3.29  3.34  3.05  3.08  130,976 
11/19/2024 3.03  3.34  3.03  3.25  303,332 
11/18/2024 3.02  3.20  3.00  3.06  271,031 
11/15/2024 3.23  3.36  3.00  3.01  428,722 
11/14/2024 3.46  3.50  3.17  3.20  431,147 
11/13/2024 4.04  4.04  3.52  3.53  208,640 
11/12/2024 3.93  4.11  3.72  3.80  222,278 
11/11/2024 3.82  4.32  3.82  4.06  307,651 
11/08/2024 3.52  3.80  3.52  3.79  382,857 
11/07/2024 3.63  3.79  3.49  3.52  362,515 
11/06/2024 3.72  3.85  3.49  3.65  469,415 
11/05/2024 3.41  3.83  3.41  3.62  395,528 
11/04/2024 3.85  3.99  3.49  3.51  705,302 
11/01/2024 3.88  3.98  3.78  3.82  238,709 
10/31/2024 4.02  4.02  3.83  3.83  179,068 
10/30/2024 4.04  4.12  3.90  3.92  175,548 
10/29/2024 4.11  4.25  3.97  4.04  414,635 
10/28/2024 4.33  4.45  4.11  4.11  211,144 
10/25/2024 4.68  4.68  4.24  4.26  258,701 
10/24/2024 4.78  4.82  4.65  4.65  155,119 
10/23/2024 4.66  4.84  4.56  4.75  645,219 
10/22/2024 4.81  4.84  4.60  4.71  324,164 
10/21/2024 4.80  5.00  4.72  4.80  161,172 
10/18/2024 4.87  5.09  4.86  5.02  196,243 
10/17/2024 4.97  4.97  4.73  4.86  193,920 
10/16/2024 5.11  5.27  4.92  5.01  270,726 
10/15/2024 5.40  5.47  4.86  5.10  471,603 
10/14/2024 5.43  5.45  5.22  5.44  302,161 
10/11/2024 5.14  5.43  5.05  5.42  332,987 
10/10/2024 5.11  5.16  4.94  5.14  668,231 
10/09/2024 5.19  5.22  5.06  5.16  206,995 
10/08/2024 5.20  5.36  5.15  5.23  320,368 
10/07/2024 5.19  5.29  5.03  5.26  341,900 
10/04/2024 5.07  5.23  4.94  5.16  485,786 
10/03/2024 5.03  5.86  4.82  5.10  455,000 
10/02/2024 5.12  5.26  5.00  5.11  803,900 
10/01/2024 5.03  5.20  4.82  5.16  756,500 
09/30/2024 4.99  5.23  4.92  5.09  735,500 
09/27/2024 5.00  5.10  4.75  4.98  585,800 
09/26/2024 5.55  5.63  4.84  5.00  1,331,400 

About Climb Bio Stock history

Climb Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Climb is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Climb Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Climb Bio stock prices may prove useful in developing a viable investing in Climb Bio
Last ReportedProjected for Next Year
Common Stock Shares Outstanding27.7 M28.6 M

Climb Bio Quarterly Net Working Capital

222.26 Million

Climb Bio Stock Technical Analysis

Climb Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Climb Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Climb Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Climb Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Climb Bio's price direction in advance. Along with the technical and fundamental analysis of Climb Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Climb to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Climb Bio is a strong investment it is important to analyze Climb Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Climb Bio's future performance. For an informed investment choice regarding Climb Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.